St. Francis Cancer Center | St. Francis Cancer Center | Available Clinical Trials
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
421
page-template,page-template-full_width_inside,page-template-full_width_inside-php,page,page-id-421,page-child,parent-pageid-283,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.9,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Available Clinical Trials

Search Clinical Trials

To view available Clinical Trials, search using the fields below. For more information about an available trial, contact our Oncology Research Department at 864-603-6211.

Available Clinical Trials

Search by Type: or
Reset

Displaying All Clinical Trials (84)
A011202
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection …
A011801
A011801 - The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response …
A021502
Alliance A021502 - Randomized Trial of Standard Chemotherapy Alone or …
A031102
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, …
A031501
A031501 - Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) …
A031704
Alliance A031704 - “PD-inhibitor (Nivolumab) and Ipilimumab followed by nivolumab …
A041501
A041501 - A Phase III Trial to Evaluate the Efficacy …
A041701
A041701 - A Randomized Phase II/III Study of Conventional Chemotherapy …
A041702
A041702 - A Randomized Phase III Study of Ibrutinib Plus …
A051301
A051301 - A randomized double-blind phase III study of ibrutinib …
A051701
A051701 - Randomized phase II/III study of venetoclax (ABT 199) …
A081801
Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST …
A151216
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). …
A211601 Companion to A011502
Evaluation of Mammographic Breast Density Effect of Aspirin: A companion …
Amgen 20190009
A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of …
Amgen 20190014
A Phase 4, Multi-center Open-label Feasibility Study to Evaluate Outpatient Blinatumomab Administration …
Apollomics APL 101-01
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, …
Arcus AB122CSP0002
A Phase 1b Study to Evaluate the Safety and Clinical …
BMS CA209-914
A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination …
CA224-104
A Phase 2 Randomized Double-blind Study of Relatlimab plus Nivolumab …
CCTG MA.39
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer …
Checkmate CMP-001-007
A Multicenter Phase 2, Open Label Study of Intratumoral CMP‐001 …
Conjupro UV1-202
A Randomized Phase II, Open‑label, Active‑controlled, Multicenter Study Investigating the Efficacy …
E4412
A Phase I Study with an Expansion Cohort/Randomized Phase II …
E4512
A Phase III Double-Blind Trial for Surgically Resected Early Stage …
EA2174
A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in …
EA2176
A Phase III Study of Immune checkpoint inhibition with chemotherapy …
EA2182
A Randomized Phase II Study of De-intensified Chemoradiation for Early …
EA3161
EA3161 - A Phase II/III Randomized Study of Maintenance Nivolumab …
EA4151
EA4151 - A Randomized Phase III Trial of Consolidation with …
EA6134
EA6134 - A Randomized Phase III Trial of Dabrafenib + …
EA6141
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim …
EA8143
EA8143 – A Phase 3 RandOmized Study Comparing PERioperative Nivolumab …
EA9131
EA9131 - A Simplified Patient Care Strategy to Decrease Early …
EAA181
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase …
EFC15858
Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel …
Galera GTI 4419-301
ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419) – …
Galera GTI-4419-203
A Phase 2A Open-Label Trial of the Effects of Intravenous …
GOG 0263
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation …
GSK 213400
A Phase 3, Randomized, Double-Blind Placebo-Controlled, Multicenter Study Comparing Niraparib …
Merck MK 3475-905
A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab …
Merck MK 4375-992
A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study …
Merck MK 7339-013
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Pembrolizumab (MK-3475) …
Merck MK3475-667
An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) …
Merck MK3475-671
A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy …
Merck MK3475-966
A Phase 3 Randomized, Double Blind Study of Pembrolizumab Plus …
NCICOVID
COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History …
NHLBI-MDS
The National Myelodysplastic Syndromes (MDS) Study
NRG-BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin …
NRG-CC004
NRG-CC004 - Phase II Double Blind Dose Finding Trial of …
NRG-CC007CD
Increasing the Dose of Survivorship Care Planning in Prostate Cancer …
NRG-GI004
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase …
NRG-GU002
NRG-GU002 - Phase II-III Trial Of Adjuvant Radiotherapy and Androgen …
NRG-GU005
Phase III IGRT and SBRT Vs IGRT and Hypofractionated IMRT …
NRG-GU009
Parallel Phase III Randomized Trials for High Risk Prostate Cancer …
NRG-GY006
A Randomized Phase II Trial of Radiation Therapy and Cisplatin …
NRG-GY009
A Randomized, Phase II/III Study of Pegylated Lipsomal Doxorubicin and …
NRG-GY018
NRG-GY018 - A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab …
NRG-HN001
Randomized Phase II and Phase III Studies of Individualized Treatment …
NRG-LU002
NRG-LU002 - Maintenance Systemic Therapy versus Consolidative Stereotactic Body Radiation …
NRG-LU005
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III …
NRG-LU007
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for …
PUMA NER-5201
AN OPEN-LABEL, PHASE 2 STUDY OF NERATINIB IN PATIENTS WITH …
QUILT 2.023
A PHASE 2, OPEN-LABEL, RANDOMIZED STUDY OF N-803, A FUSION …
QUILT 3.055
A Phase 2b, Single-Arm, Multicohort, Open-Label Study of ALT-803 in …
Razor Genomics EC-120888
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients with …
Sanofi EF15858
Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel …
Seagen SGN22E-002 (EV-103)
A study of enfortumab vedotin (ASG-22CE) as monotherapy or in …
Seagen SGN35-031
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, phase 3 study of …
Seagen SGNLVA-005
Open Label Phase II Study of Ladiratuzumab Vedotin (LV) for …
Selas Life Sciences SLS18-301
Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S …
SWOG 1608
Randomized Phase II Trial in Early Relapsing or Refractory Follicular …
SWOG 1609
DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors | …
SWOG 1714
S1714 - A Prospective Observational Cohort Study to Develop a …
SWOG 1801
S1801 - A Phase II Randomized Study of Adjuvant Versus …
SWOG 1802
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus …
SWOG 1803
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or …
SWOG 1826
S1826 - A Phase III, Randomized Study of Nivolumab (Opdivo) …
SWOG 1827
SWOG S1827 (MAVERICK) Testing Whether the Use of Brain Scans …
SWOG 1914
S1914 - A Randomized Phase III Trial of Induction/Consolidation Atezolizumab …
Theradex Bayer 20609 (DaroAct)
Bayer 20609, "A randomized, open-label, multicenter, Phase 2b study to …
URCC 18007
Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue | >>Read …
WF-1802
Influence of Primary Treatment for Prostate Cancer on Work Experience …
WF-1805
WF-1805 - Implementation and Effectiveness Trial of HN-STAR | >>Read …